{"categories":["\u5b66\u4f1a"],"type":"rich","provider_url":"https://hatena.blog","author_name":"ryamada22","height":"190","provider_name":"Hatena Blog","version":"1.0","html":"<iframe src=\"https://hatenablog-parts.com/embed?url=https%3A%2F%2Fryamada22.hatenablog.jp%2Fentry%2F20081015%2F1224097116\" title=\"HGV meeting 2008 @ Toronto - ryamada\u306e\u907a\u4f1d\u5b66\u30fb\u907a\u4f1d\u7d71\u8a08\u5b66\u30e1\u30e2\" class=\"embed-card embed-blogcard\" scrolling=\"no\" frameborder=\"0\" style=\"display: block; width: 100%; height: 190px; max-width: 500px; margin: 10px 0px;\"></iframe>","author_url":"https://blog.hatena.ne.jp/ryamada22/","blog_url":"https://ryamada22.hatenablog.jp/","width":"100%","image_url":null,"description":"CNV, Resequencing \u306b\u5411\u3051\u305f\u8a71\u3057\u304c\u4e2d\u5fc3 \u30e1\u30e2 Inversion \u306e\u691c\u51fa \u30b5\u30f3\u30d7\u30eb(\u5225\u306e\u30c7\u30fc\u30bf)\u3092\u30d7\u30fc\u30eb\u3057\u3066\u3001\u300c\u90e8\u5206\u96c6\u5408\u300d\u306e\u8003\u3048\u65b9\u3092\u5165\u308c\u3064\u3064\u3001\u60c5\u5831\u3092\u5f15\u304d\u51fa\u3059\u3068\u3044\u3046\u30a2\u30a4\u30c7\u30a3\u30a2 \u975e\u8840\u7e01\u95a2\u4fc2\u8005\u306eIBD\u691c\u51fa\u3068\u305d\u308c\u306b\u3088\u308b\u500b\u4eba\u9593\u8ddd\u96e2\u306e\u5b9a\u7fa9\u3001\u30d7\u30ed\u30c3\u30c8\u306e\u30bd\u30d5\u30c8\u30a6\u30a7\u30a2 pharmacogenomics \u306e\u30b5\u30a4\u30c8 Enhancer browser Vega annotation pseudogene \u304c\u591a\u578b\u306b\u3088\u308a\u3001gene\u306b\u683c\u4e0a\u3052\u3001\u305d\u306e\u30a2\u30ce\u30c6\u30fc\u30b7\u30e7\u30f3 HLA\u306e\u30cf\u30d7\u30ed\u30bf\u30a4\u30d7\u6570\u7a2e\u985e\u306b\u7d71\u5408\u3057\u305f\u4e0a\u3067\u30a2\u30ce\u30c6\u30fc\u30b7\u30e7\u30f3 Horton et al. PMID 18193213 microRNA TargetSca\u2026","published":"2008-10-15 03:58:36","blog_title":"ryamada\u306e\u907a\u4f1d\u5b66\u30fb\u907a\u4f1d\u7d71\u8a08\u5b66\u30e1\u30e2","url":"https://ryamada22.hatenablog.jp/entry/20081015/1224097116","title":"HGV meeting 2008 @ Toronto"}